These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10410879)

  • 21. Involvement of VEGF and its receptors in ascites tumor formation.
    Shibuya M; Luo JC; Toyoda M; Yamaguchi S
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S72-7. PubMed ID: 10357563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor and social support in patients with ovarian carcinoma.
    Lutgendorf SK; Johnsen EL; Cooper B; Anderson B; Sorosky JI; Buller RE; Sood AK
    Cancer; 2002 Aug; 95(4):808-15. PubMed ID: 12209725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
    Candido Dos Reis F; Moreira de Andrade J; Bighetti S
    Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper content in ascitic fluid is associated with angiogenesis and progression in ovarian cancer.
    Onuma T; Mizutani T; Fujita Y; Yamada S; Yoshida Y
    J Trace Elem Med Biol; 2021 Dec; 68():126865. PubMed ID: 34601284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines.
    Soh EY; Sobhi SA; Wong MG; Meng YG; Siperstein AE; Clark OH; Duh QY
    Surgery; 1996 Dec; 120(6):944-7. PubMed ID: 8957478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.
    Stimpfl M; Tong D; Fasching B; Schuster E; Obermair A; Leodolter S; Zeillinger R
    Clin Cancer Res; 2002 Jul; 8(7):2253-9. PubMed ID: 12114428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
    Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
    J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
    Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G
    Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer.
    Nakanishi Y; Kodama J; Yoshinouchi M; Tokumo K; Kamimura S; Okuda H; Kudo T
    Int J Gynecol Pathol; 1997 Jul; 16(3):256-62. PubMed ID: 9421092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.
    Belotti D; Paganoni P; Manenti L; Garofalo A; Marchini S; Taraboletti G; Giavazzi R
    Cancer Res; 2003 Sep; 63(17):5224-9. PubMed ID: 14500349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma.
    Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
    Cancer; 1998 Dec; 83(12):2528-33. PubMed ID: 9874459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease.
    Los M; Aarsman CJ; Terpstra L; Wittebol-Post D; Lips CJ; Blijham GH; Voest EE
    Ann Oncol; 1997 Oct; 8(10):1015-22. PubMed ID: 9402176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors.
    Wang J; Luo F; Lu JJ; Chen PK; Liu P; Zheng W
    Int J Cancer; 2002 Jan; 97(2):163-7. PubMed ID: 11774259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation.
    Nagy JA; Masse EM; Herzberg KT; Meyers MS; Yeo KT; Yeo TK; Sioussat TM; Dvorak HF
    Cancer Res; 1995 Jan; 55(2):360-8. PubMed ID: 7812969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity.
    Mu J; Abe Y; Tsutsui T; Yamamoto N; Tai XG; Niwa O; Tsujimura T; Sato B; Terano H; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1996 Sep; 87(9):963-71. PubMed ID: 8878460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
    Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
    Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization.
    Mesiano S; Ferrara N; Jaffe RB
    Am J Pathol; 1998 Oct; 153(4):1249-56. PubMed ID: 9777956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Markedly elevated levels of vascular endothelial growth factor in malignant ascites.
    Zebrowski BK; Liu W; Ramirez K; Akagi Y; Mills GB; Ellis LM
    Ann Surg Oncol; 1999 Jun; 6(4):373-8. PubMed ID: 10379858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma.
    Eisma RJ; Spiro JD; Kreutzer DL
    Laryngoscope; 1999 May; 109(5):687-93. PubMed ID: 10334214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers.
    Fujimoto J; Sakaguchi H; Aoki I; Khatun S; Tamaya T
    Br J Cancer; 2001 Aug; 85(3):313-6. PubMed ID: 11487257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.